Clinical Trial Update: Comparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fasting Conditions [Phase 1]

View source ↗

Summary

Phase 1 study comparing the bioavailability of 50 mg eplerenone tablets under fasting conditions; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Eplerenone (generic) (Eplerenone)

Snippet

Sponsor: Sandoz | Conditions: Hypertension | Phase 1 | Status: COMPLETED